Logo image of DCBO.CA

DOCEBO INC (DCBO.CA) Stock Fundamental Analysis

Canada - TSX:DCBO - CA25609L1058 - Common Stock

36.9 CAD
+0.6 (+1.65%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, DCBO scores 6 out of 10 in our fundamental rating. DCBO was compared to 62 industry peers in the Software industry. DCBO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DCBO is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make DCBO suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DCBO was profitable.
DCBO had a positive operating cash flow in the past year.
In multiple years DCBO reported negative net income over the last 5 years.
Of the past 5 years DCBO 4 years had a positive operating cash flow.
DCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFDCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

DCBO has a Return On Assets of 12.51%. This is amongst the best in the industry. DCBO outperforms 90.32% of its industry peers.
DCBO has a Return On Equity of 61.75%. This is amongst the best in the industry. DCBO outperforms 98.39% of its industry peers.
DCBO's Return On Invested Capital of 32.53% is amongst the best of the industry. DCBO outperforms 96.77% of its industry peers.
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROIC 32.53%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO.CA Yearly ROA, ROE, ROICDCBO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

DCBO's Profit Margin of 9.29% is amongst the best of the industry. DCBO outperforms 83.87% of its industry peers.
The Operating Margin of DCBO (9.67%) is better than 75.81% of its industry peers.
DCBO's Gross Margin of 81.00% is amongst the best of the industry. DCBO outperforms 88.71% of its industry peers.
DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.67%
PM (TTM) 9.29%
GM 81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO.CA Yearly Profit, Operating, Gross MarginsDCBO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

7

2. Health

2.1 Basic Checks

DCBO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for DCBO remains at a similar level compared to 1 year ago.
DCBO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DCBO has an improved debt to assets ratio.
DCBO.CA Yearly Shares OutstandingDCBO.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO.CA Yearly Total Debt VS Total AssetsDCBO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

DCBO has an Altman-Z score of 3.33. This indicates that DCBO is financially healthy and has little risk of bankruptcy at the moment.
DCBO has a Altman-Z score of 3.33. This is comparable to the rest of the industry: DCBO outperforms 56.45% of its industry peers.
The Debt to FCF ratio of DCBO is 0.05, which is an excellent value as it means it would take DCBO, only 0.05 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.05, DCBO belongs to the best of the industry, outperforming 95.16% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that DCBO is not too dependend on debt financing.
DCBO's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. DCBO outperforms 75.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Altman-Z 3.33
ROIC/WACC3.06
WACC10.62%
DCBO.CA Yearly LT Debt VS Equity VS FCFDCBO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.04 indicates that DCBO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.04, DCBO is in line with its industry, outperforming 41.94% of the companies in the same industry.
A Quick Ratio of 1.04 indicates that DCBO should not have too much problems paying its short term obligations.
The Quick ratio of DCBO (1.04) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
DCBO.CA Yearly Current Assets VS Current LiabilitesDCBO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.70% over the past year.
Looking at the last year, DCBO shows a quite strong growth in Revenue. The Revenue has grown by 15.11% in the last year.
Measured over the past years, DCBO shows a very strong growth in Revenue. The Revenue has been growing by 39.25% on average per year.
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%

3.2 Future

Based on estimates for the next years, DCBO will show a very strong growth in Earnings Per Share. The EPS will grow by 27.76% on average per year.
The Revenue is expected to grow by 24.94% on average over the next years. This is a very strong growth
EPS Next Y37.82%
EPS Next 2Y33.47%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DCBO.CA Yearly Revenue VS EstimatesDCBO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO.CA Yearly EPS VS EstimatesDCBO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.96, which indicates a rather expensive current valuation of DCBO.
Compared to the rest of the industry, the Price/Earnings ratio of DCBO indicates a rather cheap valuation: DCBO is cheaper than 85.48% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.42, DCBO is valued at the same level.
DCBO is valuated rather expensively with a Price/Forward Earnings ratio of 17.16.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 79.03% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.94. DCBO is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 23.96
Fwd PE 17.16
DCBO.CA Price Earnings VS Forward Price EarningsDCBO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 67.74% of the companies listed in the same industry.
DCBO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 74.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.07
EV/EBITDA 26.97
DCBO.CA Per share dataDCBO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DCBO may justify a higher PE ratio.
A more expensive valuation may be justified as DCBO's earnings are expected to grow with 34.47% in the coming years.
PEG (NY)0.63
PEG (5Y)N/A
EPS Next 2Y33.47%
EPS Next 3Y34.47%

0

5. Dividend

5.1 Amount

DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

TSX:DCBO (10/17/2025, 7:00:00 PM)

36.9

+0.6 (+1.65%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-07 2025-11-07
Inst Owners31.4%
Inst Owner ChangeN/A
Ins Owners1.51%
Ins Owner ChangeN/A
Market Cap1.06B
Analysts78.67
Price Target41.36 (12.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.06%
Min EPS beat(2)26.05%
Max EPS beat(2)28.07%
EPS beat(4)3
Avg EPS beat(4)41.65%
Min EPS beat(4)-25.3%
Max EPS beat(4)137.79%
EPS beat(8)7
Avg EPS beat(8)31.82%
EPS beat(12)10
Avg EPS beat(12)131.11%
EPS beat(16)13
Avg EPS beat(16)110.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.44%
Revenue beat(12)2
Avg Revenue beat(12)-0.71%
Revenue beat(16)3
Avg Revenue beat(16)-0.87%
PT rev (1m)0%
PT rev (3m)3.17%
EPS NQ rev (1m)1.02%
EPS NQ rev (3m)14.58%
EPS NY rev (1m)1.75%
EPS NY rev (3m)-1.21%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)1.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE 23.96
Fwd PE 17.16
P/S 3.28
P/FCF 28.07
P/OCF 26.74
P/B 21.78
P/tB 40.18
EV/EBITDA 26.97
EPS(TTM)1.54
EY4.17%
EPS(NY)2.15
Fwd EY5.83%
FCF(TTM)1.31
FCFY3.56%
OCF(TTM)1.38
OCFY3.74%
SpS11.26
BVpS1.69
TBVpS0.92
PEG (NY)0.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROCE 55.51%
ROIC 32.53%
ROICexc N/A
ROICexgc N/A
OM 9.67%
PM (TTM) 9.29%
GM 81%
FCFM 11.67%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 39.68%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 110.06%
Profit Quality 125.62%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 3.33
F-Score8
WACC10.62%
ROIC/WACC3.06
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
EPS Next Y37.82%
EPS Next 2Y33.47%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%
EBIT growth 1Y84.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year125.27%
EBIT Next 3Y50.67%
EBIT Next 5Y32.58%
FCF growth 1Y380.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y338.61%
OCF growth 3YN/A
OCF growth 5YN/A